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DOI: 10.1039/b912149hSelf-labeled magneto nanoprobes (SLMNs) were synthesized for one-step labeling of human
mesenchymal stem cells (hMSCs) via non-invasive magnetic resonance (MR) image tracking. The
surface of superparamagnetic nanocrystals (SMNCs) were enveloped by tri-aminated polysorbate 80
(TP80) not only for enhancement of the affinity for hMSCs, but also to achieve increased colloidal
stability in the aqueous phase by the nanoemulsion method. The synthesized SLMNs exhibited
excellent labeling efficiency of hMSCs and produced highly sensitive MR signals as well as safe cell
cytotoxicity.1. Introduction
Stem cell therapy has come of age for the treatment of
various diseases through cell transplantation at defunct cell
populations.1–7 The trafficking and monitoring of cell migration
during stem cell therapy is an important issue for understanding
the temporal and spatial fate and distribution of transplanted
stem cells.1,3,4,6,8–13
Because non-invaasive magnetic resonance (MR) imaging can
rapidly acquire multi-informational high resolution images,
magnetic labeling of stem cells with super-paramagnetic iron
oxide particles can provide critical information about the cellular
migration of the stem cells.2,6,7,14,15
For intracellular labeling agents, the FDA-approved ferum-
oxides have been conventionally available and can be complexed
with polycationic transfection agents (e.g. poly-L-lysine (PLL),
protamine sulfate (PS)). The positively charged surface proper-
ties of ferumoxides enable highly efficient cellular uptake
through electrostatic interactions with the negatively charged
cellular membranes.16–21
However, we have noticed that the use of ferumoxide–PLL
complexes results in oxidative stress and injury of the cells due to
formation of reactive oxygen species (ROS) and hydroxyl-free
radicals, which, may also alter cell metabolism or increase the
rate of apoptosis or cell death.10,22,23 The intracellular labeling
efficiency and long period tracking capability is dependent on the
concentration of tracking agents, even after cell differentiation.
However, the use of large amounts of labeling agents results in
increased cellular toxicity.1,8,13
The necessary and sufficient conditions for appropriate
cellular labeling with MR contrast agents are (i) a high intra-
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differentiation capacity (biocompatibility).
Herein, we synthesized self-labeled magneto nanoprobes
(SLMNs) by the nanoemulsion method using polycationic tri-
aminated polysorbate 80 (TP80) which stabilizes and envelopes
magnetic nanocrystals (MNCs) (Fig. 1). For enhancing the
cationic property and stabilizing the capability in the aqueous
phase, tri-aminated polysorbate 80 (TP80) was synthesized so
that the terminal groups of polysorbate 80 would substitute
the hydroxy groups with amine groups. We evaluated the
physico-chemical properties of nanoparticles to confirm their
nano-structures and characteristic features. Furthermore, we
carefully investigated the cellular labeling and imaging efficiency
of SLMNs using MR imaging and an in vitro MTT assay.
2. Experimental
2.1. Materials
Polysorbate 80 (polyoxyethylene sorbitan monooleate), ethyl-
enediamine (EDA), 1,10-carbonyldiimidazole (CDI), 1,4-dioxaneFig. 1 Schematic of preparation of self-labeled magneto nanoprobes
(SLMNs) for MR imaging.
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(99.8%), and poly-L-lysine were purchased from Sigma Aldrich
Chemical Co. Ferumoxides (Feridex I.V.) as commercial
magnetic resonance (MR) imaging contrast agents were provided
by the manufacturer (11.2 mg Fe/mL, Bayer HealthCare Phar-
maceuticals Inc., Wayne, NJ, USA). Phosphate buffered saline
(PBS; 10 mM, pH 7.4), DMEM and fetal bovine serum were
purchased from Gibco. Vybrant Apoptosis Assay Kit #3 was
purchased from Molecular probes (Eugene, USA). 2,4,6-Trini-
trobenzene sulfonic acid (TNBSA) was purchased from Pierce
(Thermo scientific, USA) and dialysis membrane (MWCO: 1000)
was obtained from Spectrum laboratory. Human mesenchymal
stem cells (hMSCs) were purchased from Young@science. All
other chemicals and reagents were of analytical grade.
2.2. Synthesis of MnFe2O4 nanocrystals (MNCs)
We synthesized monodispersed MnFe2O4 nanocrystals (MNCs),
which are soluble in non-polar organic solvents.24,25 Briefly,
2 mmol of iron(III) acetylacetonate, 1 mmol of manganese(II)
acetylacetonate, 10 mmol of 1,2-hexadecanediol, 6 mmol of
dodecanoic acid, and 6 mmol of dodecylamine were dissolved in
20 mL of benzyl ether under an ambient nitrogen atmosphere.
The mixture was then pre-heated to 200 C for 2 h and refluxed at
300 C for 30 min. After the reactants were cooled at room
temperature, the products were purified with an excess of pure
ethanol. Approximately 12 nm of MNCs were synthesized using
the seed-mediated growth method.
2.3. Synthesis of tri-aminated polysorbate 80 (TP80)
To modify the surface of MNCs with amine groups, we first
synthesized tri-aminated polysorbate 80 (TP80) using CDI asFig. 2 (a) Synthetic diagram of tri-aminated polysorbate 80 (TP80) and
(b) the determination of amine groups in tri-aminated polysorbate 80
(TP80) and glycine using TNBS assay.
This journal is ª The Royal Society of Chemistry 2009a zero-length crosslinker (Fig. 2 (a)).26,27 5 mmol of P80 and
15 mmol of CDI were dissolved in a flask containing 100 mL of
1,4-dioxane and the reactant solution was stirred for 1 h.
Subsequently, 15 mmol of EDA was added into the reactor at
room temperature. After further reaction for 24 h, the un-wanted
solvent was rapidly eliminated using a rotary evaporator. The
obtained transparent gel type product was then dissolved in
10 mL of deionized water and dialyzed against excess aqueous
phase for over seven days. The purified product was freeze-dried
and stored under vacuum for later use. The chemical structure
of TP80 was characterized by 1H-NMR (400 MHz, Varian
INOVA400 NMR spectrometer) using CDCl3 as a solvent. The
characteristic bands of synthesized TP80 and P80 were confirmed
by Fourier-transform infrared spectroscopy (FT-IR, Varian,
Excalibur series).
2.4. Determination of amine groups in TP80
To measure the primary amine groups in TP80, which were
dissolved in 0.1 M sodium bicarbonate buffer (pH 8.5) at various
concentrations (8.33–133.21 mM), 0.5 mL of TP80 solution was
mixed with a 0.01% (w/v) TNBSA solution. Subsequently, the
mixed solution was stored at 37 C for 2 h. Then we added
0.25 ml of 1% sodium dodecyl sulfate (SDS) and 0.125 ml of 1 M
hydrochloride (HCl) to the TP80 solution. As a control, glycine
was prepared in the same manner. The absorbance of TP80 and
glycine solution was analyzed using a UV-Vis spectrometer at
355 nm (Optizen 2120UV, MECASYS Co.).
2.5. Preparation of self-labeled magneto nanoprobes (SLMNs)
SLMNs were prepared by nanoemulsion method.28 50 mg of
MNCs were dissolved in 4 mL of hexane (as the organic phase)
and the organic phase was mixed with 20 mL of phosphate buffer
saline (as the aqueous phase) containing 100 mg of TP80. After
mutual saturation of organic and aqueous phases, the emulsion
was ultra-sonicated in an ice-cooled bath for 10 min at 450 W.
The organic solvent was evaporated overnight at room temper-
ature and the products were purified by centrifugal filter
(Centriprep YM-3, 3 kDa NMWL, Amicon and USA) with two
cycles at 3000 g force for 1 h. The amount of amine groups in the
SLMNs were measured by a TNBSA assay. The size distribution
and zeta-potential of SLMNs were analyzed using laser scat-
tering (ELS-Z, Otsuka electronics). The surface electrical charge
of the prepared SLMNs was analyzed by gel electrophoresis in
1% agarose in buffer solution over a wide range of pH conditions
(pH 3–11) at room temperature. The morphologies of SLMNs
were confirmed using high resolution transmission electron
microscope (HR-TEM, JEM-2100F, JEOL Ltd.). The magnetic
properties of MNCs and SLMNs were evaluated using
a vibrating-sample magnetometer (VSM; MODEL-7300, Lake-
shore) at 298 K and the residual weight ratio (%) of the MNCs in
the SLMNs was analyzed with a thermo-gravimetric analyzer
(SDT-Q600, TA instrument).
2.6. Cell viability test of SLMNs against hMSCs
The cytotoxic effect of SLMNs against hMSCs was evaluated by
measuring the inhibition of cell growth using MTT assay. Briefly,
hMSCs were seeded at a density of 1  104 cells/well in a 96-wellJ. Mater. Chem., 2009, 19, 8958–8963 | 8959
plate and incubated overnight at 37 C. hMSCs were then
incubated with SLMNs at various concentrations for 24 h. The
yellow tetrazolium salt of the MTT solution is reduced to
purple formazan crystals in metabolically alive cells. The cell
viabilities were obtained by calculating the ratio of the intensity
of purple formazan in viable cells treated with SLMNs to the
intensity in untreated control cells. Human mesenchymal stem
cells (hMSCs) were seeded at a density of 1  106 cells/well in
a culture flask for a week at 37 C and incubated with 80 mg
mL1 of SLMNs with a medium containing serum for a further
24 h. Then hMSCs incubated with SLMNs were collected by
centrifugation and washed twice with phosphate buffer saline
(6.7 mM, pH 7.4).
Further to confirm whether labeled SLMNs caused cellular
damage of hMSCs, i.e., apoptosis and necrosis, we performed an
annexin V-FITC/propidium iodide (PI) double staining test.29,30
After resuspending hMSCs in 100 mL of 1X annexin-binding
buffer, 5 mL of annexin V-FITC solution and 1 mL of PI
solutions were injected and incubated with hMSCs for 15 min at
room temperature in a dark room. The fluorescence-stained
hMSCs were analyzed by FACScalibur (Beckton-Dickinson,
Mansfield, MA) by monitoring the fluorescence activated cell
after addition of an additional 400 mL of 1X annexin-binding
buffer.2.7. Cellular labeling efficiency of SLMNs
Human mesenchymal stem cells (1  106 cells/well) were
incubated for a week in a culture dish and were then further
incubated with SLMNs (80 mg mL1) containing a medium with
serum in 5% CO2 for 24 h at 37
C. Subsequently, hMSCs treated
with SLMNs were washed twice with phosphate buffered
solution (pH 7.4 and 10 mM), trypsinized (0.5 mM), and har-
vested. The collected hMSCs were washed in triplicate using
0.2% fetal bovine serum and 0.02% NaN3 in phosphate buffered
solution (pH 7.4 and 10 mM). The MR imaging capability of
SLMNs was estimated by MR imaging, Prussian blue staining
(BX51 upright microscope, Olympus) and transmission electron
microscopy (TEM, JEOL-1100). Furthermore, the concentration
of hMNCs (Fe + Mn) of labeled SLMNs into hMSCs was
determined by inductively coupled plasma automic emission
spectroscopy (ICP-AES, Elan 6100, Perkin Elmer).2.8. In vitro MR imaging procedure
All MR imaging experiments were performed with a 1.5 T
clinical MRI instrument with a micro-47 surface coil (Intera;
Philips Medical Systems, Best, the Netherlands). The T2 weights
of the SLMNs solution and ferumoxides and hMSC treated with
SLMNs were measured by the Carr–Purcell–Meiboom–Gill
(CPMG) sequence at room temperature: TR ¼ 10 s, 32 echoes
with 12 milliseconds even echo space, number of acquisition ¼ 1,
point resolution of 156  156 mm, section thickness of 0.6 mm.
For T2-weighted MR imaging of the samples, the following
parameters were adopted: resolution of 234  234 mm, section
thickness of 2.0 mm, TE ¼ 60 milliseconds, TR ¼ 4000
milliseconds and the number of acquisitions ¼ 1. The relaxivity
coefficient (mM1 s1) is equal to the ratio of R2 (1/T2, s1)
to SLMNs and ferumoxides concentration.8960 | J. Mater. Chem., 2009, 19, 8958–89632.9. Statistical analysis
All experiments were performed in triplicate and the values
are expressed as the average  standard deviation. The
statistical evaluation of the data was performed by analysis of
variance (ANOVA), followed by Turkey’s test for comparison
of cell viability, and relative T2 signal in MR image from
different groups. A p < 0.01 was considered to be statistically
significant.3. Results and discussion
For the synthesis of SLMNs, the tri-hydroxyl group of poly-
sorbate 80 (P80) was first modified with amine groups using
ethylenediamine (EDA) and 1,10-carbonyldiimidazole (CDI) as
a zero-length cross linker. The synthetic scheme of tri-amine
terminated polysorbate 80 (TP80) is depicted in Fig. 2 (a). First,
the tri-hydroxyl groups of P80 were activated with CDI, and the
conjugated imidazole group of activated P80 was attacked by the
amine group of EDA. Finally, a stable carbamate bond was
formed by coupling the hydroxyl group from P80 and an amine
group from EDA.26,27 After the conjugation process, the chem-
ical structure of TP80 was characterized using 1H-NMR; d values
of 2.0 (–NH2), 2.91, 3.22 (–CH2–) and 7.11 (–NH–) (ESI†).
Furthermore, the characteristic bands of TP80 were verified by
FT-IR spectra; 3550 cm1 (N–H stretching of amine group),
3400 cm1 (C–N stretching of an amide group), 2400 cm1
(O–CO–CH3 stretching) and 1600 cm
1 (N–H bending of and
amine group) (ESI†). Otherwise, the hydroxyl stretching at
3500 cm1 from TP80 was no longer observed after modification
of P80 terminal groups. The increment of molecular weights for
TP80 was further confirmed using gel permeation chromatog-
raphy (GPC). The retention time of tri-amine terminated poly-
sorbate 80 was decreased compared to non-modified P80 due to
conjugated EDA (ESI†). The absorbance of the reactants was
detected in proportion to the amount of amine groups (–NH2)
because TNBS (2,4,6-trinitrobenzene sulfonic acid) was reacted
with an amine group and produced a chromogenic derivative. As
shown in Fig. 2 (b), the absorbance of TP80 was three times
higher in comparison with the one of glycine through the TNBS
assay. These results confirmed that the tri-hydroxyl group of P80
were successfully modified with tri-amine groups.
To utilize the MR capability of SLMNs, the hydrophobic
magnetic nanocrystals (MNCs) were encapsulated with amphi-
philic TP80. The size and the zeta-potential value of SLMNs
measured by laser scattering were 40.73  4.63 nm and 25.36 
1.87 mV, respectively. The size of the SLMNs was larger than the
hydrophobic magnetic nanocrystals because the hydrophilic
parts (–OCH2CH2–) of tri-aminated polysorbate 80 (TP80) on
the surface of SLMNs were conjugated with water molecules via
hydrogen bonding. Furthermore, the TEM image presented
well dispersed SLMNs in the aqueous phase without any
precipitation and aggregation (ESI†).
The size of SLMNs was smaller compared to ferumoxides
(commercial MR imaging agents, 62.30  2.94 nm) (*p < 0.01).
Because of the large amounts (2.78  1020 ea/mL) of amine
groups (–NH2) on the surface of SLMNs, the zeta-potential
value exhibited a strong positive charge compared with ferum-
oxide (24.79  0.37 mV) (Fig. 3 (a)).This journal is ª The Royal Society of Chemistry 2009
Fig. 3 (a) Size distribution and zeta-potential, (b) gel electrophoresis
analysis of self-labeled magneto nanoprobes (SLMNs) and ferumoxides
and (c) zeta-potential of SLMNs against pH condition (*p < 0.01).
Fig. 4 (a) Thermogravimetric analysis of self-labeled magneto nanop-
robes (SLMNs) and (b) magnetic hysteresis loops of MNCs (black solid
line) and SLMNs (red solid line).
Fig. 5 (a) T2-weighted MR images and (b) relaxivity (R2) graph versus
various concentrations of self-labeled magneto nanoprobes (SLMNs)
(;) compared to ferumoxides (C).Since cell membranes are mainly composed of phospholipids,
which contain negatively charged phosphate groups, strong
positively charged SLMNs can enhance cellular affinity and
the labeling efficiency by electrostatic interaction. Hence, we
envisage that SLMNs are suitable labeling agents even without
the use of transfection agents. The nitrogen atom of the amine
group featured a lone electron pair that can bind with hydrogen
protons (H+) of the water molecules to form an ammonium ion
(NH3
+).31 In Fig. 3 (b), gel electrophoresis analysis revealed
that the band of SLMNs was shifted towards the anode
(downward) due to the positive surface charge of SLMNs when
100 V of voltage was applied to the gel matrix. Furthermore, we
confirmed the variation of zeta-potentials and stability of
SLMNs according to various pH conditions (Fig. 3 (c) and
ESI†). Because the nitrogen atoms of amine groups interacted
with the hydrogen protons (H+) in acidic condition, the surface of
the SLMNs exhibited a positive charge below pH 8. In basic
conditions, the nitrogen atoms were bereft of hydrogen ions (H+)
in the amine groups, and the surface charges were negative above
pH 8. The results indicated that SLMNs exhibit positive charges
under biological conditions.32
While the amount of encapsulated MNCs in SLMNs was 70
wt% through thermogravimetric analysis, SLMNs exhibited
superparamagnetic behavior at 298 K without remanence
and coercivity and the saturation of magnetization at 0.8 T of
SLMNs was 32.28 emu/g MNCs, which was similar to that of
naked MNCs (39.76 emu/g MNCs) (Fig. 4).
To evaluate the utility of SLMNs as ultrasensitive labeling
agents via MR imaging, we investigated MR images of the
SLMN solutions and the signal intensities of SLMNs and then
compared them with ferumoxide as a commercial MR imaging
agent. The SLMN solution resulted in a stronger black color
T2-weighted MR images and the corresponding relaxivity
coefficient was 383.73 mM1 s1 indicating that SLMNs wereThis journal is ª The Royal Society of Chemistry 2009sufficiently sensitive labeling agents as compared with
ferumoxide (190.47 mM1 s1) (Fig. 5).
As shown in Fig. 6 (a), in vitro cytotoxic activity measured by
MTT assay showed that the cell viability of SLMNs retained
over 80% of the concentration of 100 mg Fe + Mn/mL. In
addition, we performed the biocompatibility test of SLMNs
against hMSCs through the annexin V-FIT C/propidium iodide
(PI) double stain method to investigate whether SLMNs may
induce apoptosis. In apoptotic cells, phosphatidylserine (PS) was
exposed to the outer cell membrane and annexin V had a high
affinity to PS as a phospholipid binding protein, since the
integrity of the cell membrane was breaking. PI was also used for
distinction of dead or damaged cells, because PI penetrates into
the membrane of dead or damaged cells. In Fig. 6 (b), SLMN
(80 mg Fe + Mn/mL)-treated hMSCs were detected in the lower
left quadrant (99.51%) and did not stain with either annexin
V-FITC and PI, which is comparable to results with non-treated
control cells (97.21%). Also, the rate of apoptotic and necrotic
cells did not differ between SLMN- treated and non-treated cells.
The results demonstrate that SLMNs do not induce apoptosis
and necrosis in hMSCs.J. Mater. Chem., 2009, 19, 8958–8963 | 8961
Fig. 6 (a) Cell viability of human mesenchymal stem cells (hMSCs)
treated with various concentrations of self-labeled magneto nanoprobes
(SLMNs) and (b) biocompatibility test of hMSCs treated with
SLMNs using apoptosis detection assay (annexin V-FITC/PI double
stain method); the numbers in all of the FACS data represent the
percentages of each cell death mechanism: the percentages (%) of cells
suffering necrotic death (annexin V/PI+; upper left), apoptotic cells
(annexin V+/PI; lower right), late apoptotic or secondary necrotic
death (annexin V+/PI+; upper right) and live cells (annexin V/PI;
lower left).
Fig. 7 (a) T2-weighted MR images and relaxivity (R2) graph (b) Prus-
sian blue staining images, (c) TEM images of human mesenchymal stem
cells (hMSCs) treated with self-labeled magneto nanoprobes (SLMNs)
(80 mg Fe + Mn/mL). The red arrow of TEM images indicates the
existence of SLMNs in hMSCs. And (d) dispersed in a microtube with
a Nd–B–Fe magnetic field of hMSCSs treated with SLMNs for 1 min
(scale bar: 100 mm. *p < 0.01).We next evaluated the labeling efficiency of SLMNs
against hMSCs through MR contrast effect at 1.5 T. In the
T2-weighted MR images, a significant MR contrast effect was
observed in SLMN-treated cells (black color) compared to
non-treated control cells (bright gray color) (Fig. 7 (a)). The
calculated R2 relaxivity value of hMSCs treated with SLMNs
exhibited consistent results showing 253.81 s1 (1408.12%,
DR2/R2 non-treatment), which is much higher than that for
non-treated cells (*p < 0.01, Fig. 7 (a)). Furthermore, the results
from Prussian blue staining and cellular TEM images showed
similar results. Prussian blue and ferric ions of the MNCs
rapidly exchange electrons thereby producing dark blue colors
in the intra-cellular region. In Fig. 7 (b), the image of
SLMN-treated hMSCs demonstrated significant MNC uptake
manifested as numerous blue spots, indicating MNCs in the
cytoplasm. In contrast, no dark blue spots were observed for
the non-treated cells. In the cellular TEM image, the black
clusters of hMSCs treated with SLMNs indicated the engulf-
ment of SLMNs into the intra-cellular region (Fig. 7 (c)). The
content of the MNCs was 0.19 mg Fe + Mn per 5.0  105 cells
(measured by ICP-AES). Fig. 7 (d) shows the strongly gathered
SLMN-treated hMSCs upon external magnetic field (Nd–B–Fe
magnet, 0.3 T) for 1 min indicating the excellent magnetic
properties of SLMNs.
Through the varieties of physical, chemical and biological
experiments, the synthesized SLMNs demonstrated sufficient
capability as ultrasensitive self-labeling and tracking agents via
MR imaging.8962 | J. Mater. Chem., 2009, 19, 8958–8963Conclusions
For cell tracking and monitoring via MR imaging, we success-
fully synthesized self-labeled magneto nanoprobes (SLMNs) for
detection of human mesenchymal stem cells (hMSCs) without
using additional transfection agents. Efficient and successful
encapsulation of MNCs using tri-aminated polysorbate 80
(TP80) without loss of magnetic sensitivity produces highly water
soluble nanoparticles as well as strong positively charged surface
characteristics. These biologically safe and cationic SLMNs may
be a potentially powerful and efficient cell tracking nanoprobe to
use with MR imaging.Acknowledgements
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